-
Hua Medicine Announces at 2025 ADA Scientific Sessions that Dorzagliatin Combined With DPP-4 Inhibitor Shows Promise in Reducing Blood Lipids While Restoring Glucose Homeosta
ACN Newswire
June 23, 2025
Hua Medicine announced today that the Company presented the latest research results of dorzagliatin, its global first-in-class glucokinase activator (GKA), at the 85th Scientific Sessions of the American Diabetes Association (ADA).
-
Holidays Complicate Diabetes Management, Patients Report
drugs
December 23, 2021
Nearly half of U.S. adults living with type 2 diabetes say managing their condition is more difficult during the fall and winter holiday season than other times of the year...
-
ADA: Peds Hospitalization Rates for New-Onset T2DM Up During Pandemic
drugs
July 05, 2021
Hospitalization rates for new-onset pediatric type 2 diabetes increased during the COVID-19 pandemic, according to a study presented at the annual meeting of the American Diabetes Association, held virtually from June 25 to 29.
-
The American Diabetes Association Praises Introduction of Affordable Insulin for the COVID-19 Emergency Act and the Minority Diabetes Initiative Act
prnewswire
March 25, 2021
The American Diabetes Association® (ADA) announced its strong support today for the Affordable Insulin for the COVID-19 Emergency Act (H.R. 2179) and the Minority Diabetes Initiative Act (H.R. 2178), both introduced this week by Representative Maxine ...
-
ADA: Lilly, Boehringer's DPP-4 drug Tradjenta ties generic rival in heart safety study
fiercepharma
June 12, 2019
Boehringer Ingelheim and Eli Lilly have already shown that Tradjenta doesn’t hurt patients’ hearts. But the pair is back with even more supporting evidence that they hope will bolster the drug's profile in a competitive field.
-
No 'One-Size-Fits-All' Diet for Diabetics, Expert Panel Says
drugs
April 19, 2019
There is no one right diet for people with diabetes, and patients should instead have personalized nutrition plans, a new American Diabetes Association (ADA) report says.